Stockscreener 앱 받기
4.69
4.09%
-0.20
시장 영업 전:
4.69
Curis Inc 주식(CRIS)의 최신 뉴스
Curis Inc (CRIS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Curis Gains As Blood Cancer Drug Progresses, December Readout in Focus - Yahoo Finance
CRIS|Curis Inc|Price:5.190|Chg%:+0.300 - TradingKey
TradingKey - TradingKey
Curis Inc (CRIS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Curis Inc (CRIS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Curis Inc (CRIS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CRIS Maintained by HC Wainwright & Co. -- Price Target Raised to $43.00 - GuruFocus
Curis, Inc. Revenue Breakdown – NASDAQ:CRIS - TradingView
Curis Inc (CRIS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CRIS Q2'26 Earnings: revenue estimate is 1.00M USD - TradingView
Curis stock jumps 11% on positive emavusertib trial data - Investing.com
Curis Strengthens Oncology Pipeline Outlook With Strong TakeAim Lymphoma Response Rates - Benzinga
Curis (CRIS) Stock Sees Fair Value Lift As Analysts Back Leadership And Consumer Focus - Yahoo Finance
Curis Q2 2026: Updated Clinical Data for Emavusertib Trials - grafa.com
Curis stock jumps 11% on positive emavusertib trial data By Investing.com - Investing.com South Africa
Curis Inc Positive Emavusertib Update Transcript - GuruFocus
Curis shares surge after updated emavusertib data strengthens clinical outlook (NASDAQ:CRIS) - Yahoo Finance
Curis reports updated trial data for emavusertib in lymphoma By Investing.com - Investing.com Nigeria
Curis reports updated trial data for emavusertib in lymphoma - Investing.com
Curis Announces Positive Emavusertib Update - PR Newswire
Why did Curis (CRIS) stock soar after hours? - MSN
FRA:CUS1 EPS (Basic): €-20.76 | Significantly Overvalued - GuruFocus
Curis (FRA:CUS1) Graham Number : €N/A (As of Mar. 2026) - GuruFocus
Curis Inc Annual Shareholders Meeting Transcript - GuruFocus
Curis (FRA:CUS1) Marketable Securities : €0.00 Mil (As of Mar. 2026) - GuruFocus
FRA:CUS1 EV-to-EBITDA: 0.69 — 35% Above Median - GuruFocus
Q2 2025 Curis Inc Earnings Call Transcript - GuruFocus
Q1 2026 Curis Inc Earnings Call Transcript - GuruFocus
Q3 2025 Curis Inc Earnings Call Transcript - GuruFocus
Curis Inc (FRA:CUS1) Stock Price & 30 Year Financial Data - GuruFocus
Curis Inc (FRA:CUS1)Valuation Measures & Financial Statistics - GuruFocus
Curis Inc (FRA:CUS1) Stock Earnings Transcripts - GuruFocus
Curis Inc (FRA:CUS1) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Equity in earnings of Curis, Inc. – SWB:CUS1 - TradingView
Price to book forward of Curis, Inc. – SWB:CUS1 - TradingView
Long term debt to total equity ratio of Curis, Inc. – SWB:CUS1 - TradingView
Curis Inc. (CRIS) Holds Near Support Amid Slight Uptick – Key Levels in FocusDividend Stock Picks - dars.gov.et
Net margin % of Curis, Inc. – DUS:CUS1 - TradingView
Net current asset value per share of Curis, Inc. – DUS:CUS1 - TradingView
Curis Inc. (CRIS) Shares Slide Nearly 10% as Biotech Faces Key Support TestFast Moving Stocks - dars.gov.et
Form 4 Curis Inc For: 9 July By Investing.com - Investing.com Nigeria
Director Marc Rubin receives 6,800 Curis (CRIS) stock options at $5.29 - Stock Titan
Curis (CRIS) director receives grant of 6,800 non-qualified stock options - Stock Titan
Curis (CRIS) director John Hohneker receives 6,800 stock options at $5.29 - Stock Titan
Curis Inc (CRIS) director receives 6,800 stock options at $5.29 - Stock Titan
CURIS INC (CRIS) director granted 6,800 non-qualified stock options at $5.29 - Stock Titan
CURIS (CRIS) CFO receives 48,285 stock options at $5.29 exercise price - Stock Titan
Curis (CRIS) CDO Jonathan Zung receives 48,285 stock options at $5.29 strike - Stock Titan
Curis (CRIS) CEO receives 110,090 employee stock options at $5.29 - Stock Titan
Price to book forward of Curis, Inc. – HAM:CUS1 - TradingView
Return on invested capital % of Curis, Inc. – HAM:CUS1 - TradingView
Net income of Curis, Inc. – HAM:CUS1 - TradingView
Curis | 4: Statement of changes in beneficial ownership of securities-Director KAITIN KENNETH I - Moomoo
Free cash flow per share of Curis, Inc. – LSX:A42DTL - TradingView
Price to book forward of Curis, Inc. – FWB:CUS1 - TradingView
Return on assets % of Curis, Inc. – LSX:A42DTL - TradingView
Debt to equity ratio of Curis, Inc. – FWB:CUS1 - TradingView
Return on equity % of Curis, Inc. – FWB:CUS1 - TradingView
Net income of Curis, Inc. – GETTEX:CUS1 - TradingView
Gross profit of Curis, Inc. – FWB:CUS1 - TradingView
Net income of Curis, Inc. – LS:A42DTL - TradingView
Price to book forward of Curis, Inc. – MUN:CUS1 - TradingView
Operating expenses (excl. COGS) of Curis, Inc. – MUN:CUS1 - TradingView
Curis stock edges into a thin-day update. - Ad-hoc-news.de
Number of employees of Curis, Inc. – MUN:CUS1 - TradingView
1.97%
0.83%
자본화:
|
볼륨(24시간):